Using proteomics to uncover extracellular matrix interactions during cardiac remodeling

Nicolle L. Patterson, Rugmani Padmanabhan Iyer, Lisandra E. de Castro Brás, Yaojun Li, Thomas G. Andrews, Gregory J. Aune, Richard A. Lange, Merry L. Lindsey

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

The left ventricle (LV) responds to a myocardial infarction with an orchestrated sequence of events that result in fundamental changes to both the structure and function of the myocardium. This collection of responses is termed as LV remodeling. Myocardial ischemia resulting in necrosis is the initiating event that culminates in the formation of an extracellular matrix (ECM) rich infarct scar that replaces necrotic myocytes. While the cardiomyocyte is the major cell type that responds to ischemia, infiltrating leukocytes and cardiac fibroblasts coordinate the subsequent wound healing response. The matrix metalloproteinase family of enzymes regulates the inflammatory and ECM responses that modulate scar formation. Matridomics is the proteomic evaluation focused on ECM, while degradomics is the proteomic evaluation of proteases as well as their inhibitors and substrates. This review will summarize the use of proteomics to better understand matrix metalloproteinase roles in post myocardial infarction LV remodeling.

Original languageEnglish (US)
Pages (from-to)516-527
Number of pages12
JournalProteomics - Clinical Applications
Volume7
Issue number7-8
DOIs
StatePublished - Aug 1 2013

Fingerprint

Proteomics
Extracellular Matrix
Ventricular Remodeling
Matrix Metalloproteinases
Cicatrix
Myocardial Infarction
Fibroblasts
Protease Inhibitors
Cardiac Myocytes
Wound Healing
Muscle Cells
Heart Ventricles
Myocardial Ischemia
Myocardium
Leukocytes
Peptide Hydrolases
Necrosis
Ischemia
Substrates
Enzymes

Keywords

  • Degradomics
  • Matridomics
  • Matrix metalloproteinases
  • Myocardial infarction

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Patterson, N. L., Iyer, R. P., de Castro Brás, L. E., Li, Y., Andrews, T. G., Aune, G. J., ... Lindsey, M. L. (2013). Using proteomics to uncover extracellular matrix interactions during cardiac remodeling. Proteomics - Clinical Applications, 7(7-8), 516-527. https://doi.org/10.1002/prca.201200100

Using proteomics to uncover extracellular matrix interactions during cardiac remodeling. / Patterson, Nicolle L.; Iyer, Rugmani Padmanabhan; de Castro Brás, Lisandra E.; Li, Yaojun; Andrews, Thomas G.; Aune, Gregory J.; Lange, Richard A.; Lindsey, Merry L.

In: Proteomics - Clinical Applications, Vol. 7, No. 7-8, 01.08.2013, p. 516-527.

Research output: Contribution to journalReview article

Patterson, NL, Iyer, RP, de Castro Brás, LE, Li, Y, Andrews, TG, Aune, GJ, Lange, RA & Lindsey, ML 2013, 'Using proteomics to uncover extracellular matrix interactions during cardiac remodeling', Proteomics - Clinical Applications, vol. 7, no. 7-8, pp. 516-527. https://doi.org/10.1002/prca.201200100
Patterson NL, Iyer RP, de Castro Brás LE, Li Y, Andrews TG, Aune GJ et al. Using proteomics to uncover extracellular matrix interactions during cardiac remodeling. Proteomics - Clinical Applications. 2013 Aug 1;7(7-8):516-527. https://doi.org/10.1002/prca.201200100
Patterson, Nicolle L. ; Iyer, Rugmani Padmanabhan ; de Castro Brás, Lisandra E. ; Li, Yaojun ; Andrews, Thomas G. ; Aune, Gregory J. ; Lange, Richard A. ; Lindsey, Merry L. / Using proteomics to uncover extracellular matrix interactions during cardiac remodeling. In: Proteomics - Clinical Applications. 2013 ; Vol. 7, No. 7-8. pp. 516-527.
@article{c7e5ff7dec9c4f62bc916f9e41d3f612,
title = "Using proteomics to uncover extracellular matrix interactions during cardiac remodeling",
abstract = "The left ventricle (LV) responds to a myocardial infarction with an orchestrated sequence of events that result in fundamental changes to both the structure and function of the myocardium. This collection of responses is termed as LV remodeling. Myocardial ischemia resulting in necrosis is the initiating event that culminates in the formation of an extracellular matrix (ECM) rich infarct scar that replaces necrotic myocytes. While the cardiomyocyte is the major cell type that responds to ischemia, infiltrating leukocytes and cardiac fibroblasts coordinate the subsequent wound healing response. The matrix metalloproteinase family of enzymes regulates the inflammatory and ECM responses that modulate scar formation. Matridomics is the proteomic evaluation focused on ECM, while degradomics is the proteomic evaluation of proteases as well as their inhibitors and substrates. This review will summarize the use of proteomics to better understand matrix metalloproteinase roles in post myocardial infarction LV remodeling.",
keywords = "Degradomics, Matridomics, Matrix metalloproteinases, Myocardial infarction",
author = "Patterson, {Nicolle L.} and Iyer, {Rugmani Padmanabhan} and {de Castro Br{\'a}s}, {Lisandra E.} and Yaojun Li and Andrews, {Thomas G.} and Aune, {Gregory J.} and Lange, {Richard A.} and Lindsey, {Merry L.}",
year = "2013",
month = "8",
day = "1",
doi = "10.1002/prca.201200100",
language = "English (US)",
volume = "7",
pages = "516--527",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley-VCH Verlag",
number = "7-8",

}

TY - JOUR

T1 - Using proteomics to uncover extracellular matrix interactions during cardiac remodeling

AU - Patterson, Nicolle L.

AU - Iyer, Rugmani Padmanabhan

AU - de Castro Brás, Lisandra E.

AU - Li, Yaojun

AU - Andrews, Thomas G.

AU - Aune, Gregory J.

AU - Lange, Richard A.

AU - Lindsey, Merry L.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - The left ventricle (LV) responds to a myocardial infarction with an orchestrated sequence of events that result in fundamental changes to both the structure and function of the myocardium. This collection of responses is termed as LV remodeling. Myocardial ischemia resulting in necrosis is the initiating event that culminates in the formation of an extracellular matrix (ECM) rich infarct scar that replaces necrotic myocytes. While the cardiomyocyte is the major cell type that responds to ischemia, infiltrating leukocytes and cardiac fibroblasts coordinate the subsequent wound healing response. The matrix metalloproteinase family of enzymes regulates the inflammatory and ECM responses that modulate scar formation. Matridomics is the proteomic evaluation focused on ECM, while degradomics is the proteomic evaluation of proteases as well as their inhibitors and substrates. This review will summarize the use of proteomics to better understand matrix metalloproteinase roles in post myocardial infarction LV remodeling.

AB - The left ventricle (LV) responds to a myocardial infarction with an orchestrated sequence of events that result in fundamental changes to both the structure and function of the myocardium. This collection of responses is termed as LV remodeling. Myocardial ischemia resulting in necrosis is the initiating event that culminates in the formation of an extracellular matrix (ECM) rich infarct scar that replaces necrotic myocytes. While the cardiomyocyte is the major cell type that responds to ischemia, infiltrating leukocytes and cardiac fibroblasts coordinate the subsequent wound healing response. The matrix metalloproteinase family of enzymes regulates the inflammatory and ECM responses that modulate scar formation. Matridomics is the proteomic evaluation focused on ECM, while degradomics is the proteomic evaluation of proteases as well as their inhibitors and substrates. This review will summarize the use of proteomics to better understand matrix metalloproteinase roles in post myocardial infarction LV remodeling.

KW - Degradomics

KW - Matridomics

KW - Matrix metalloproteinases

KW - Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=84881517471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881517471&partnerID=8YFLogxK

U2 - 10.1002/prca.201200100

DO - 10.1002/prca.201200100

M3 - Review article

C2 - 23532927

AN - SCOPUS:84881517471

VL - 7

SP - 516

EP - 527

JO - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 7-8

ER -